Aptevo Therapeutics
APVO
APVO
12 hedge funds and large institutions have $352K invested in Aptevo Therapeutics in 2023 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 2 increasing their positions, 4 reducing their positions, and 1 closing their positions.
Holders
12
Holders Change
+3
Holders Change %
+33.33%
% of All Funds
0.18%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
2
Reduced
4
Closed
1
Calls
$8K
Puts
–
Net Calls
+$8K
Net Calls Change
+$8K
Top Buyers
| 1 |
1
Renaissance Technologies
New York
|
$94K |
| 2 |
2
Citadel Advisors
Miami,
Florida
|
$47.4K |
| 3 |
3
Squarepoint
New York
|
$25.1K |
| 4 |
4
Millennium Management
New York
|
$18.9K |
| 5 |
SSA
5
Schonfeld Strategic Advisors
New York
|
$28.8K |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
AF
26
Allworth Financial
Folsom,
California
| $4 | -$6 | – | – |
|
27
Citigroup
New York
| $2 | -$3 | – | – |
|
28
UBS Group
Zurich,
Switzerland
| $1 | -$28 | – | – |
|
29
Bank of America
Charlotte,
North Carolina
| $1 | -$2 | – | – |
|
30
T. Rowe Price Associates
Baltimore,
Maryland
| – | -$16K | -1 | Closed |
|
31
EARNEST Partners
Atlanta,
Georgia
| – | -$5 | – | – |
|